Home
ALX Oncology Inc

ALX Oncology Inc Market Share Analysis for June 2026

We’re dedicated to expanding the possibilities for patients by developing novel approaches to optimize current and future standards of care.

Health > Biotechnology and Pharmaceuticals

Domainalxoncology.com

Year Founded2015

Employees51 - 200

Annual Revenue$5M - $10M

ALX Oncology Inc

ALX Oncology Inc (including company regionals)

alxoncology.com

See more website traffic and engagement information

ALX Oncology Inc Revenue up to June 2026 is 5M - 10M

revenue generated by ALX Oncology Inc top domains

ALX Oncology Inc top domains revenue over 3 years

Revenue for ALX Oncology Inc top domains

alxoncology.com5M - 10M

See more with Sales Intelligence

Total visits to ALX Oncology Inc's top domains

Understand ALX Oncology Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

alxoncology.com4.7K

See more with Sales Intelligence

Avg. visit duration in ALX Oncology Inc's top domains

Analyze ALX Oncology Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

alxoncology.com00:00:55

See more with Sales Intelligence

Avg. pageviews on ALX Oncology Inc's top domains

See how ALX Oncology Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

alxoncology.com2.45

See more with Sales Intelligence

ALX Oncology Inc top competitors by domain

Top similar sites in June 2026, ranked by their affinity

astellasgenetherapies.comCompany NameAstellas Gene TherapiesEmployees201 - 500HQUnited States, California, San FranciscoAnnual revenue$75M - $100MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by ALX Oncology Inc

These are the website technologies, by industry, used by ALX Oncology Inc top domains

Widget (5)

Twemoji

Email Services (4)

G Suite

Marketing (4)

Google Marketing Platform

Advertising (2)

DoubleClick

More Technologies

8

See all

News & Signals from ALX Oncology Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsALX Oncology Inc. hired Scott Garland as Chairman of the Board of Directors on Jun 30th '26.ALX Oncology appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel.

NewsALX Oncology Inc. attended event ESMO Breast Cancer 2026 on Jan 1st '26.ALX Oncology (Nasdaq: ALXO) will present exploratory CD47 biomarker data from its Phase 1b/2 trial of evorpacept plus zanidatamab in heavily pretreated HER2-positive metastatic breast cancer at ESMO Breast Cancer 2026 on May 7, 2026.